What Trump's Generic Drug Tariffs Could Cost Americans Now
Policy experts say what trump's generic drug tariffs could mean for prices and supplies is uncertain, with effects de...
Check which passive funds beat the market in 2024 retirement planning and what factors contributed to their outperformance.
28,482 articlesPolicy experts say what trump's generic drug tariffs could mean for prices and supplies is uncertain, with effects de...
Amazon unveils a sweeping $200 billion capex plan focused on AWS and AI infra, prompting investor debate on the compa...
The Internal Revenue Service has floated a plan to require crypto exchanges to deliver tax forms electronically to us...
A surge in AI-focused crypto has investors weighing a $500 bet. This article breaks down how the technology works, th...
A wave of generative AI tools is upending Microsoft’s per-seat Office model. With Copilot seats climbing and pricing ...
XRP strengthens on both USD and BTC markets as momentum turns bullish, crossing key thresholds and drawing investor a...
Bitget unveils Reality, a new tokenization platform delivering tokenized access to select U.S. stocks and ETFs as mar...
A tidal wave of data centers is pushing power demands higher. Five dividend stocks are quietly funding the grid expan...
Confused by Rocket Lab's stock moves? This guide explains the core forces behind RKLB, how the business is evolving, ...
Galaxy Research trims its forecast for the Clarity Act 2026 to 50% odds, citing a crowded Senate schedule and slow ne...
Bitcoin hovers near $70,000 as Iran-driven energy volatility cools and policy expectations shift, setting up a pivota...
The FDA has issued a recall of Elite Treats Chicken Chips for Dogs due to potential salmonella contamination. No illn...